This inventor holds 1 USPTO granted patent, plus 2 CIPO patents. Top assignee: Mcgill University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Dusan Garic: Innovator in Ion Transporter Activity Enhancement
Introduction
Dusan Garic is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of ion transporter activity, particularly in relation to channelopathies. His innovative work has the potential to impact treatments for various medical conditions.
Latest Patents
Dusan Garic holds a patent titled "Compositions and methods for enhancing ion transporter activity and uses thereof." This patent describes methods for enhancing the activity of an ion transporter in a cell and treating a channelopathy in a subject. The methods involve the administration of an effective amount of a fenretinide compound or zinc. These approaches are useful for restoring or increasing the cell surface expression of ion transporters, such as the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), which may be mutated or defective. The combination of fenretinide and/or zinc with ion transporter modulators can further enhance the expression and activity of these transporters.
Career Highlights
Dusan Garic is affiliated with McGill University, where he conducts research and develops innovative solutions in his field. His work is characterized by a commitment to advancing scientific knowledge and improving patient outcomes.
Collaborations
Dusan collaborates with esteemed colleagues, including John Hanrahan and Danuta Radzioch. These partnerships enhance the research and development of effective treatments for channelopathies.
Conclusion
Dusan Garic is a pioneering inventor whose work in enhancing ion transporter activity holds promise for medical advancements. His contributions to the field are significant and reflect his dedication to improving health outcomes through innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
